Gevo, Inc. (NASDAQ:GEVO) Files An 8-K Entry into a Material Definitive AgreementItem 1.01.
On January4, 2018, Gevo, Inc. (the “Company”) entered into a private exchange agreement (the “Exchange Agreement”) with a holder of its 7.5% convertible senior notes due 2022 (the “2022 Notes”) to exchange $515,000 of principal amount of 2022 Notes for 780,303 shares of its common stock (the “Exchange Shares”).Upon completion of this exchange, the 2022 Notes will be paid off in full and there will be no remaining obligations under the 2022 Notes.
The Exchange Shares are being issued in reliance on the exemption from registration provided by Section3(a)(9) of the Securities Act of 1933, as amended, as securities exchanged by the Company with its existing security holders exclusively where no commission or other remuneration is paid or given directly or indirectly for soliciting the exchange.
| Item 1.01. | Unregistered Sales of Equity Securities. |
The information provided in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 1.01.
About Gevo, Inc. (NASDAQ:GEVO)
Gevo, Inc. (Gevo) is a renewable chemicals and next generation biofuels company. The Company has developed a technology that uses a combination of synthetic biology, metabolic engineering, chemistry and chemical engineering to focus primarily on the production of isobutanol, as well as related products from renewable feedstock. It has two operating segments: the Gevo, Inc. segment and the Gevo Development/Agri-Energy segment. Its Gevo, Inc. segment is responsible for research and development activities related to the future production of isobutanol, including the development of its biocatalysts, the production and sale of biojet fuel, its Retrofit process and the next generation of chemicals and biofuels that will be based on its isobutanol technology. Its Gevo Development/Agri-Energy segment is responsible for the operation of its Agri-Energy Facility and the production of ethanol, isobutanol and related products.
